
PCUK Career Acceleration Fellow @UniofOxford 🇬🇧 working to improve radionuclide treatment of prostate cancer with novel drug combinations💊+☢️.
Oxford
Joined April 2020
- Tweets139
- Following335
- Followers331
- Likes226
Had a great time talking about the radiobiology of alphas and betas at the High Country Nuclear Medicine conference in Park City, Utah. Thank you again for the invitation. I also had a great time skiing for the first time in 16 years, such a treat.
Just a reminder there is still time to apply (closing 7th March) for a Postdoc investigating the metabolic signatures in #prostatecancer 🦴 mets w/ PET imaging for tailored☢️+💊 combos.
•Funder
@PCF_Science
•Co-supervision
@ProfClaireEd
tinyurl.com/4a6em88f
#metabolism
Reminder there is still time to apply (closing tomorrow, 17th January) for these positions on an exciting project to determine how prostate cancer metabolism affects its radioresistance against 177LuPSMA and more importantly how to overcome this resistance.
Postdoc/RA jobs in new #radiobiology group @unioxford
•Funder @PCF_Science
•Co-supervision @ProfClaireEd
•Collab with @OxPCaBiol
Project: Identify metabolic signatures in #prostatecancer 🦴 mets w/ PET imaging for tailored 💊 + ☢️combos
t.ly/3iIrL
Cl 17 Jan
Edward O'Neill retweeted
Postdoc/RA jobs in new #radiobiology group @unioxford
•Funder @PCF_Science
•Co-supervision @ProfClaireEd
•Collab with @OxPCaBiol
Project: Identify metabolic signatures in #prostatecancer 🦴 mets w/ PET imaging for tailored 💊 + ☢️combos
t.ly/3iIrL
Cl 17 Jan
Postdoc/RA jobs in new #radiobiology group @unioxford
•Funder @PCF_Science
•Co-supervision @ProfClaireEd
•Collab with @OxPCaBiol
Project: Identify metabolic signatures in #prostatecancer 🦴 mets w/ PET imaging for tailored 💊 + ☢️combos
t.ly/3iIrL
Cl 17 Jan
Edward O'Neill retweeted
UK contingent at #PCFRetreat23 Fantastic science, and so great to catch up with friends and colleagues after 4y! Thanks @PCF_Science
Edward O'Neill retweeted
We are thrilled to announced that Dr Edward O'Neill will join our department after securing a prestigious Prostate Cancer UK Career Acceleration Fellowship. Congrats and welcome to NDS, @NuclearMedEd! 🎉
➡️ nds.ox.ac.uk/news/edward-one…
@ProstateUKProfs @ProstateUKPress @ProstateUK
1/ Excited to share my new paper out in Theranostics highlighting the potentially beneficial role of acheiving senescence with lutetium-177 based therapies by imaging the changes in the DNA damage response.
thno.org/v13p1302.htm
13/ This story was an interesting demonstration of the power of preclinical molecular imaging to develop a novel non-magnitude based metric with SPECT, that also revealed something biologically interesting - the potentially beneficial role senescence induction by 177Lu
Thanks again to @The_MRC for originally funding this original work, and @PCR_News for additional support, as well as @Cornelissen_Lab and @The_OIRO, @OxfordOncology @OxfordMedSci











